Maravai LifeSciences (MRVI) Tops Q4 EPS by 2c, beats on guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: MRVI) | Delayed: 7.27 +0.20 (2.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.07 | 52 Week High | $ | |||
| Open | $7.03 | 52 Week Low | $ | |||
| Day High | $7.29 | P/E | N/A | |||
| Day Low | $6.98 | EPS | $ | |||
| Volume | 562,462 | |||||
